They found that although in TILs, TAZ/YAP levels correlated with an increased response to neoadjuvant chemotherapy due to increased clonal expansions of CD8+ T cells, this was not the case in cancer cells, where TAZ/YAP levels correlated with poor prognosis [34]. This evidence concerns the gene YAP1 and cancer.